Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: A double-blind, placebo-controlled, ascending-dose trial

This publication has 14 references indexed in Scilit:

• Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure
  Published by Elsevier ,2004
• Nesiritide Does Not Improve Renal Function in Patients With Chronic Heart Failure and Worsening Serum Creatinine
  Circulation, 2004
• Clinical applications of B-type natriuretic peptide (BNP) testing
  European Heart Journal, 2003
• Cyclic GMP Production by ANP, BNP, and NO during Worsening and Improvement of Chronic Heart Failure
  Japanese Heart Journal, 2003
• The renal urodilatin system: clinical implications
  Cardiovascular Research, 2001
• Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: A randomized, double-blind, placebo-controlled clinical trial
  Published by Elsevier ,1999
• Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure
  American Heart Journal, 1995
• Haemodynamic and renal effects of urodilatin bolus injections in patients with congestive heart failure
  European Journal of Clinical Investigation, 1992
• Mechanisms involved in the response to prolonged infusion of atrial natriuretic factor in patients with chronic heart failure.
  Circulation, 1991
• Isolation and structural analysis of “Urodilatin”, a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine
  Journal of Molecular Medicine, 1988